OrbiMed Advisors LLC, 10% owner, sold 1,000,000 shares of PMVP at $1.52 on 2025-10-23 for $1,520,000.00; holdings down to 4,975,291 shares post-transaction
OrbiMed Advisors LLC reduced its PMVP stake by 1,000,000 shares (reducing holdings to 4,975,291 shares), executing the sale at $1.52 when the stock traded at $1.58 post-transaction. This transaction occurred in a context of company fundamentals marked by negative net income of $-21,210,000.00 and a market cap of $83,725,565.12. Across OrbiMed's historical open-market activity, prior sells have been well-timed 78.57% of the time (measuring whether the stock declined within 90 days of sale), suggesting a pattern of disciplined exit timing. However, this specific transaction cannot be characterized as having early forward timing signals, as the current price of $1.58 stands only 3.9% above the sale price, and the stock remains -11.2% from its 52-week high. What warrants attention is the material reduction in position size—a -16.7% decrease in holdings by a 10% stakeholder—at a company with sustained unprofitability.